Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • United Kingdom No evidence of young people moving from vape to tobacco…
  • Europe EC reveals environmental claims proposal…
  • United States FDA publishes list of tobacco-related petitions…
  • Cambodia Education minister tells schools to crack down on heated tobacco…
  • United Kingdom Ad breached the code by showing under-25s using heated tobacco…
  • Czech Republic Nicotine pouches come under tobacco regulations…
  • Maine - United States Possible ban on all flavoured tobacco products…
  • Taiwan Heated tobacco regulation and e-cig ban come into force…
  • United Kingdom ‘Smokefree 2030’ – government promises proposals soon…
  • United Kingdom Counterfeit cigarettes and other nicotine products seized…
  • Malta Petition calls for heated tobacco to be legalised…
  • Italy Ministers plan tax reform for tobacco and nicotine sales network…
View all
News analysis

US FDA grants modified risk orders to PMI’s Iqos and Marlboro HeatSticks

Written by || 7th July 2020 || News analysis | Heated tobacco | IQOS | North America United States

The US Food and Drug Administration (FDA) has granted Philip Morris International (PMI) modified risk tobacco product (MRTP) status for Iqos and its associated HeatSticks ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

Italian health ministry says IQOS ‘reduced-risk’ claim is unproven
PMI lowers expectation of IQOS uptake by half as lockdown hits Heets sales
FDA gives the green light for IQOS roll-out onto the US market
© 2023
TobaccoIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of TobaccoIntelligence,
does not accept any liability or responsibility for information or views published.